MSN Laboratories initiates phase-III trial of Molnupiravir

Clinical trials will be performed on more than 2,400 subjects suffering from mild-to-moderate Covid-19

Comments

Popular posts from this blog

BJP’s victory in local body polls indicator of coming Assembly polls: Bommai

Karnataka: BJP MLA used HIV positive women to honey trap rivals, probe launched

MUDA case: Karnataka HC rejects Siddaramaiah’s plea against Governor move